ProofPilot, founded as an American internet company, specializes in public health, behavioral health, and market research. Its core mission is to streamline and enhance the research process by eliminating burdens and reducing protocol deviations. ProofPilot offers a Digital Protocol Automation platform designed to optimize recruitment and conduct for clinical trials, ensuring high-performance experiences for both sites and patients. The company focuses on providing innovative solutions that improve the efficiency and effectiveness of clinical research.
Notable achievements include a significant case study where Eli Lilly reduced clinical trial costs by 67% using ProofPilot's platform. The company has made a substantial impact in the field by addressing common challenges in clinical trials, such as protocol deviations and participant recruitment. By leveraging digital automation, ProofPilot has positioned itself as a transformative force in the research industry, contributing to more efficient and cost-effective clinical studies.
